Dechra Pharmaceuticals PLC Director/PDMR Shareholding (6798A)
26 Septiembre 2022 - 9:01AM
UK Regulatory
TIDMDPH
RNS Number : 6798A
Dechra Pharmaceuticals PLC
26 September 2022
26 September 2022
Dechra(R) Pharmaceuticals PLC
(Dechra or the Company)
Notification and public disclosure of transactions by
persons discharging managerial responsibilities (PDMRs)
Dechra Pharmaceuticals PLC announces that on 23 September 2022,
it was notified that on 22 September 2022, the following PDMRs sold
the shares set out below (acquired pursuant to the Dechra
Pharmaceuticals PLC Long Term Incentive Plan (the LTIP)
exercise/vesting announced on 22 September 2022) in order to fund
the resulting tax liability. In accordance with the Company's
Directors' Remuneration Policy, the remaining shares must be
retained for a period of two years from the date of vesting.
Name Capacity Shares Sale Price Total beneficial Percentage
Sold per share shareholding of issued
following this share capital
announcement
--------------- ---------- ------ ---------- ----------------- ---------------
Ian Page Director 10,834 GBP27.808 404,535 0.36%
Paul Sandland Director 1,936 GBP27.808 11,714 0.01%
Tony Griffin Director 3,608 GBP27.808 37,049 0.03%
--------------- ---------- ------ ---------- ----------------- ---------------
The Notification of Dealing Forms set out below are provided in
accordance with the requirements of the UK Market Abuse
Regulation.
Notification of Dealing Forms
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Ian Page
--------------------------------- ------------------------------------------
2. Reason for the notification
-----------------------------------------------------------------------------
a) Position/status Director/PDMR
--------------------------------- ------------------------------------------
b) Initial notification/ Initial Notification
amendment
--------------------------------- ------------------------------------------
3. Details of the Issuer
-----------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
--------------------------------- ------------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
--------------------------------- ------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where
transactions have been conducted
-----------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial
instrument ISIN: GB0009633180
Identification
code
--------------------------------- ------------------------------------------
b) Nature of the Partial sale of shares obtained under
transaction the Company's Long Term Incentive Plan
to satisfy tax liability
--------------------------------- ------------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBP27.807816 10,834
--------------------------------- ------------------------ ----------------
d) Aggregated information
* Aggregate volume 10,834
GBP27.807816
GBP301,269.88
* Price
* Total
--------------------------------- ------------------------------------------
e) Date of the transaction 2022.09.22
--------------------------------- ------------------------------------------
f) Place of the transaction London Stock Exchange
--------------------------------- ------------------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Paul Sandland
--------------------------------- ----------------------------------------
2. Reason for the notification
---------------------------------------------------------------------------
a) Position/status Director/PDMR
--------------------------------- ----------------------------------------
b) Initial notification/ Initial Notification
amendment
--------------------------------- ----------------------------------------
3. Details of the Issuer
---------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
--------------------------------- ----------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
--------------------------------- ----------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
---------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial instrument
Identification ISIN: GB0009633180
code
--------------------------------- ----------------------------------------
b) Nature of the transaction Partial sale of shares obtained under
the Company's Long Term Incentive
Plan to satisfy tax liability
--------------------------------- ----------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBP27.807816 1,936
--------------------------------- ----------------------- ---------------
d) Aggregated information
* Aggregate volume 1,936
GBP27.807816
GBP53,835.93
* Price
* Total
--------------------------------- ----------------------------------------
e) Date of the transaction 2022.09.22
--------------------------------- ----------------------------------------
f) Place of the transaction London Stock Exchange
--------------------------------- ----------------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Tony Griffin
--------------------------------- ----------------------------------------
2. Reason for the notification
---------------------------------------------------------------------------
a) Position/status Director/PDMR
--------------------------------- ----------------------------------------
b) Initial notification/ Initial Notification
amendment
--------------------------------- ----------------------------------------
3. Details of the Issuer
---------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
--------------------------------- ----------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
--------------------------------- ----------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
---------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial instrument
Identification ISIN: GB0009633180
code
--------------------------------- ----------------------------------------
b) Nature of the transaction Partial sale of shares obtained under
the Company's Long Term Incentive
Plan to satisfy tax liability
--------------------------------- ----------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBP27.807816 3,608
--------------------------------- ----------------------- ---------------
d) Aggregated information
* Aggregate volume 3,608
GBP27.807816
GBP100,330.60
* Price
* Total
--------------------------------- ----------------------------------------
e) Date of the transaction 2022.09.22
--------------------------------- ----------------------------------------
f) Place of the transaction London Stock Exchange
--------------------------------- ----------------------------------------
For further information, please contact:
Melanie Hall, Company Secretary
Telephone: 01606 814730
About Dechra
Dechra is a global specialist veterinary pharmaceuticals and
related products business. Our expertise is in the development,
manufacture, and sales and marketing of high quality products
exclusively for veterinarians worldwide. For more information
please visit: www.dechra.com .
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of
Dechra Pharmaceuticals PLC.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHBXGDCCUDDGDL
(END) Dow Jones Newswires
September 26, 2022 10:01 ET (14:01 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Dechra Pharmaceuticals (LSE:DPH)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
